Jump to the Content

Bonumose files Patent for Breakthrough Galactose Technology

PLANT-BASED GALACTOSE FROM BONUMOSE BIOCHEM LLC

Bonumose is pleased to announce the development of its enzymatic pathway for production of low-cost, plant-based galactose. Galactose and other recent ingredient developments are further extensions of Bonumose’s breakthrough enzymatic technology platform for the production of affordable healthy sugars such as tagatose, allulose, allose and mannose. Bonumose’s galactose patent application was filed on April 3, 2017.

 

Galactose

Galactose commonly is derived from lactose (milk sugar), a disaccharide consisting of galactose and glucose molecules. For a variety of reasons, companies such as DuPont® Danisco® developed processes for non-animal derived galactose as an alternative to animal-derived galactose. But the cost of those processes remain comparatively high.

Bonumose’s process, on the other hand, starts with low-cost, plant-based, commodity feedstock (starch); does not involve harsh processing conditions or require costly separations of intermediates; and will produce extremely high yields using food-grade enzymes…

Read the full press release here.

The CvilleBioHub was created to inform and connect the biotech and life sciences community, to provide pathways for growth and to promote the area as a center for this dynamic industry